E80.20
Unspecified porphyria
Clinical Classification Guidelines
Inclusion Terms
- Porphyria NOS
Medical Intelligence & Overview
Unspecified porphyria, classified under ICD-10 code E80.20, is a broad term used when the specific type of porphyria a person has cannot be determined or when detailed diagnosis has not been made. Porphyria refers to a group of rare disorders involving abnormal production of heme, an essential component of hemoglobin in red blood cells. This disruption causes a buildup of natural chemicals called porphyrins, which can lead to various symptoms affecting the skin or nervous system. Because of its unspecified nature, this diagnosis covers a wide array of potential symptoms and causes, making understanding and management complex but vital for affected individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes involved in heme production Environmental factors triggering symptom outbreaks in genetically predisposed individuals Certain medications, especially those causing enzyme inhibition in heme synthesis Exposure to chemicals or toxins that interfere with enzyme activity Hormonal changes, such as those during menstrual cycles or pregnancy Dietary factors influencing enzyme activity and porphyrin levels
Key Symptoms: Skin-related symptoms including severe photosensitivity, blistering, and redness when exposed to sunlight Neurological symptoms such as muscle weakness, abdominal pain, nausea, vomiting, and mental disturbances Fatigue and general malaise Dark or reddish urine, especially after sun exposure Difficulty tolerating sunlight, leading to skin damage
Diagnostic & Treatment
Diagnosis Path: Urinary porphyrin tests to detect elevated porphyrin levels Blood tests assessing porphyrin concentrations and enzyme activity Stool analysis for porphyrin metabolites Genetic testing to identify specific mutations if the type of porphyria is suspected Skin biopsies in cases with prominent dermatological symptoms
Treatment Protocols: Avoidance of sunlight and protective clothing to manage photosensitivity Use of skin protectants and topical treatments for skin lesions Intravenous heme therapy during acute attacks to decrease porphyrin production Pain management with appropriate medications Beta-carotene supplements to reduce photosensitivity symptoms Hormonal regulation if hormonal fluctuations trigger symptoms Managing triggers like certain medications or environmental exposures Regular monitoring and supportive care in severe cases
Clinical Advice & FAQs
Billing Guidance
Is E80.20 a billable ICD-10 code?
Yes, E80.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E80.20?
Clinical documentation must specify the nature of Unspecified porphyria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference